IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 180 filers reported holding IMPAX LABORATORIES INC in Q1 2014. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,628,000 | -4.1% | 50,844 | +30.6% | 0.00% | 0.0% |
| Q4 2015 | $1,698,000 | +0.6% | 38,922 | -18.8% | 0.00% | 0.0% |
| Q3 2015 | $1,688,000 | -39.4% | 47,958 | -20.9% | 0.00% | -25.0% |
| Q2 2015 | $2,785,000 | -7.9% | 60,643 | -6.0% | 0.00% | -33.3% |
| Q1 2015 | $3,023,000 | +10.2% | 64,501 | -24.7% | 0.01% | +20.0% |
| Q4 2014 | $2,743,000 | -51.5% | 85,686 | -64.1% | 0.01% | -50.0% |
| Q3 2014 | $5,652,000 | +56.2% | 238,394 | +54.2% | 0.01% | +66.7% |
| Q2 2014 | $3,619,000 | +484.7% | 154,606 | +560.0% | 0.01% | +500.0% |
| Q1 2014 | $619,000 | -40.1% | 23,424 | -46.5% | 0.00% | -50.0% |
| Q4 2013 | $1,033,000 | +118.9% | 43,824 | +90.4% | 0.00% | +100.0% |
| Q3 2013 | $472,000 | +604.5% | 23,015 | +589.1% | 0.00% | – |
| Q2 2013 | $67,000 | – | 3,340 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |